Extract NASA PUMA Licensing Terms via FOIA Intelligence
- Organization
- NASA Glenn Research Center
- Sector
- All potential PUMA licensees (defense, aviation, medical, fitness)
- Location
- United States
Source reference
Executive summary
Current state
NASA's validated PUMA hypoxia-prediction technology with F-22 flight test data is licensable but currently only licensed for fitness applications, creating a pricing arbitrage between NASA's institutional rates and defense/commercial aviation's urgent safety needs.
Market catalyst
NASA's PUMA technology licensing terms, AirFlare LLC's restrictions, and fee structures are buried in government documents while multiple markets (defense, commercial aviation, medical) desperately need validated hypoxia monitoring solutions but lack visibility into licensing availability.
This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.
Field notes
Intelligence ledger
Add new evidence, corrections, or practical context to this directive. Keep claims attributable to a source where possible.
Sign in to add intelligence or vote on a field note.
Field intel logs: [ 0 ] entries. No operative updates submitted for this directive. Submit intel to claim clearance.